Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;~* Visual acuity of 20/40 to 20/80 or better (Snellen equivalent).~Exclusion Criteria:~* Clinically relevant ophthalmic or systemic conditions may be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): IOP Dorzolamide-Timolol-Brimonidine group
- B (Type: ACTIVE_COMPARATOR): IOP dorzolamide-timolol group

Based on this trial design, predict the completion outcome and termination type (if applicable).